For the past several years, the availability of Ig products has been very good, so product shortages have not played a major role in product choice. This gives clinicians the opportunity to match the best product to the patient based on the patient's clinical condition and comorbidities.

Download to read this article in PDF document:
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations 

This article is in PDF format and it requires Abobe Reader. If you do not have Adobe Reader installed on your computer then please download and install from the link below.